|
|
|
|
|
Your Trusted Supplier of Innovative and High-Performance Life Science
Reagents
|
|
|
|
|
|
|
|
|
Tocris Bioscience에서 줄기세포 치료제
개발을 위해 최초로 GMP Small Molecules를 출시했습니다.
현재 SB431542 및 DAPT가 출시됐으며 연내로 Y-27632, CHIR 99021,
XAV 939가 출시될 예정입니다.
이제 줄기세포 치료제 연구에도 GMP Small
Molecule을 사용해 보세요!
|
|
|
|
|
|
|
|
|
|
|
|
GMP Compounds from Tocris
|
|
|
|
|
|
Product Name
|
Description
|
Status
|
|
SB 431542
|
TGF-β1, ALK4 and ALK7 inhibitor. Replaces SOX2 in
reprogramming of fibroblasts to iPSCs
|
Available
|
|
DAPT
|
γ-secretase inhibitor; Notch pathway inhibitor.
Causes stem cells to commit to neuronal differentiation
|
Available
|
|
Y-27632
|
Selective ROCK inhibitor. Increases survival rate
of ESCs and iPSCs undergoing cryopreservation
|
Coming soon
|
|
CHIR 99021
|
Highly selective GSK-3 inhibitor; WNT pathway
activator. Enables reprogramming of human somatic cells into iPS cells
|
Coming soon
|
|
XAV 939
|
Potent tankyrase inhibitor; Inhibits WNT
Signaling. Promotescardiomyocyte differentiation from ESCs
|
Coming soon
|
|
|
|
|
|
|
|
|
|
|
|
|
GMP
Small Molecules의 특징
|
|
|
|
|
•
|
A
quality assured manufacturing system
|
|
|
•
|
Guaranteed
batch-to-batch consistency
|
|
|
|
|
|
|
•
|
Bioburden
and endotoxin tested compounds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GMP Proteins from Our Sister Brand, R&D
Systems
|
|
|
|
|
|
|
|
|
|
R&D
systems에서 세포 치료제 생산을 위해 특별히 제작된 GMP protein을 제공합니다.
Consistency, Safety 등 R&D systems에서
제공해 드릴 수 있는 장점들에 대해 알아보세요!
|
|
|
|
|
|
|
|
|
|
|
|
